What is Heartflow, Inc. Common Stock (HTFL)?

Heartflow, Inc. Common Stock (HTFL) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

What is the current price of HTFL?

The current price of HTFL is $57.82. Prices are updated in real time on Stocks360.

What is HTFL's price-to-earnings (PE) ratio?

HTFL's trailing twelve-month PE ratio is -40.72, based on current price and earnings per share data available on Stocks360.

What is HTFL's market capitalization?

HTFL's market capitalization is $5,027,658,482.00, placing it in the mid-cap tier.

Heartflow, Inc. Common Stock (HTFL)

Stock analysis · NASDAQ · Healthcare · Medical - Healthcare Information Services

$57.82

Market Cap

$5.03B

PE (TTM)

-40.72

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.02

Day Range

$55.99 – $59.90

52-wk Range

$20.13 – $59.90

Avg Volume

N/A

Volume

1.79M

Heartflow, Inc. Common Stock (HTFL) is a publicly traded company in the Healthcare sector. Latest price: $57.82. Market cap $5.03B. Trailing PE -40.72. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $38.30 2026-10-27 · $57.82 (+50.97%)

Earnings

Most Recent

Aug 13, 2026

EPS $-0.07 vs est. $-0.13

Beat by $0.06

Next Earnings

Nov 12, 2026

EPS estimate $-0.10

Proprietary Signals

Signal snapshot temporarily unavailable.

About Heartflow, Inc. Common Stock

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-40.72×
P/S (TTM)	23.71×
P/B	17.86×
PEG	5.63×
P/FCF (TTM)	-84.95×
EV / EBITDA	-47.38×
EV / Sales	23.67×
Earnings Yield	-2.37%
Free Cash Flow Yield	-1.18%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.02B
Revenue (TTM)	$212.07M
Net Income (TTM)	-$119.13M
Free Cash Flow (TTM)	-$55.72M
Net Debt	-$7.24M
Working Capital	$179.88M
Gross Margin	80.08%
Operating Margin	-34.31%
Net Margin	-55.82%
Return on Equity	-42.25%
Return on Invested Capital	-23.67%

Peers

CDIO

Cardio Diagnostics Holdings, Inc.